Nafamostat Mesilate, a Potent Serine Protease Inhibitor, Inhibits Airway Eosinophilic Inflammation and Airway Epithelial Remodeling in a Murine Model of Allergic Asthma-Reference-Cited by-同舟云学术

Nafamostat Mesilate, a Potent Serine Protease Inhibitor, Inhibits Airway Eosinophilic Inflammation and Airway Epithelial Remodeling in a Murine Model of Allergic Asthma

Published:2008 Issue:3 Volume:108 Page:355-363
ISSN:1347-8613
Container-title:Journal of Pharmacological Sciences
language:en
Short-container-title:J Pharmacol Sci

Author:

Ishizaki Masayuki,Tanaka Hiroyuki,Kajiwara Daisuke,Toyohara Tatsuyuki,Wakahara Keiko,Inagaki Naoki,Nagai Hiroichi

Publisher

Japanese Pharmacological Society

Subject

Pharmacology,Molecular Medicine

Reference48 articles.

1. 1 Bousquet J, Jeffery PK, Busse WW, Johnson M, Vignola AM. Asthma. From bronchoconstriction to airways inflammation and remodeling. Am J Respir Crit Care Med. 2000;161:1720–1745.

2. Asthma and inflammation

3. 3 Metcalfe DD, Baram D, Mekori YA. Mast cells. Physiol Rev. 1997;77:1033–1079.

4. 4 Wenzel SE, Fowler AA 3rd, Schwartz LB. Activation of pulmonary mast cells by bronchoalveolar allergen challenge. In vivo release of histamine and tryptase in atopic subjects with and without asthma. Am Rev Respir Dis. 1988;137:1002–1008.

5. 5 Fahy JV, Liu J, Wong H, Boushey HA. Cellular and biochemical analysis of induced sputum from asthmatic and from healthy subjects. Am Rev Respir Dis. 1993;147:1126–1131.

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Airborne indoor allergen serine proteases and their contribution to sensitisation and activation of innate immunity in allergic airway disease;European Respiratory Review;2024-04-24

2. The Role of the Nuclear Factor-Kappa B (NF-κB) Pathway in SARS-CoV-2 Infection;Pathogens;2024-02-12

3. Nafamostat has anti-asthmatic effects associated with suppressed pro-inflammatory gene expression, eosinophil infiltration and airway hyperreactivity;Frontiers in Immunology;2023-04-21

4. Effect of postoperative administration of nafamostat mesilate on posthepatectomy liver failure;HPB;2022-09

5. Pharmacokinetics of Nafamostat, a Potent Serine Protease Inhibitor, by a Novel LC-MS/MS Analysis;Molecules;2022-03-14